Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov 30;14(11):e246700.
doi: 10.1136/bcr-2021-246700.

COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis

Kazuki Takasaki  1 , Takazumi Tsunenari  2 , Kazuma Mori  3 , Satsuki Aochi  3
Affiliations
Case Reports

COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis

Kazuki Takasaki et al. BMJ Case Rep. .

Abstract

A 40-year-old man was admitted to our hospital for COVID-19. He had been treated for essential thrombocythemia (ET). He was diagnosed severe illness of COVID-19, oxygen therapy and dexamethasone were administered. There was a possibility of thromboembolic events in this case, apixaban for prophylaxis was added. With these treatments, the patient has made a good recovery, and he was discharged on hospital day 11. There is no standard strategy for prophylaxis of thrombosis in patients with ET, and apixaban could be a clinical benefit for these patients.

Keywords: COVID-19; medical management.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Contrast-enhanced CT showed multilobar ground grass opacities in both lungs.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Machhi J, Herskovitz J, Senan AM, et al. . The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol 2020;15:359–86. 10.1007/s11481-020-09944-5 - DOI - PMC - PubMed
    1. Nopp S, Moik F, Jilma B, et al. . Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis. Res Pract Thromb Haemost 2020;4:1178–91. 10.1002/rth2.12439 - DOI - PMC - PubMed
    1. Barbui T, De Stefano V, Alvarez-Larran A, et al. . Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. Blood Cancer J 2021;11:21. 10.1038/s41408-021-00417-3 - DOI - PMC - PubMed
    1. National Institutes of Health . COVID-19 treatment guidelines, 2021. Available: https://www.covid19treatmentguidelines.nih.gov/about-the-guidelines/ [Accessed 1 Sep 2021]. - PubMed
    1. Horiuchi H, Morishita E, Urano T, et al. . COVID-19-Related thrombosis in Japan: final report of a questionnaire-based survey in 2020. J Atheroscler Thromb 2021;28:406–16. 10.5551/jat.RPT001 - DOI - PMC - PubMed

Publication types